Corcept Therapeutics Operating Income

Corcept Therapeutics (CORT) currently reports a operating income of $6.4M as of June 2026. That compares with $100M in the prior-year period — down 93.7% year over year. Use the charts on this page to explore Corcept Therapeutics's operating income history and peer comparisons.

Corcept Therapeutics's operating income decreased from $100M to $6.4M — a 93.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Corcept Therapeutics reported $6.4M in operating income as of June 2026. That compares with $100M in the prior-year period — down 93.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $6.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Corcept Therapeutics, and consider following CORT for alerts when major investors trade the stock.

Corcept Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $6.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CORT with unrelated industries.